PROHANCE sol inj 5 mmol/10ml ser préremp

7680525990401 CH-52599 V08CA04 14.02.0.
PROHANCE sol inj 5 mmol/10ml ser préremp
PROHANCE sol inj 5 mmol/10ml ser préremp
1 / 2
google

Details

Product number
5259901
CPT
-
Packaging group
1 x 10
Unit
ml
Composition
gadoteridolum 279.3 mg corresp. 0.5 mmol, calteridolum calcicum, trometamolum, acidum hydrochloridum aut natrii hydroxidum corresp. natrium max. 5.75 µg, aqua ad iniectabile ad solutionem pro 1 ml.

Articles (1)

ProHance 0.5 mmol/ml, soluzione iniettabile (siringa di iniezione preriempita)
soluzione iniettabile (siringa di iniezione preriempita)
1 x 10
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
279.3 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 63.70
Specialties list
Yes
Generic
No
SL addition date: 01/03/2018

Authorization holder

Bracco Suisse SA

6814 Cadempino

Authorization information

Swissmedic authorization number
52599
Drug name
ProHance 0.5 mmol/ml, soluzione iniettabile (siringa di iniezione preriempita)
Galenic form
INLFS
ATC Code
V08CA04
Authorization status
Z
Dispensation category
B
First authorization
15/12/2000
Authorization expiration date
31/12/9999
IT number
14.02.0.
Domain
Human medicine

Packaging details

Description (FR)
PROHANCE sol inj 5 mmol/10ml ser préremp
Description (DE)
PROHANCE Inj Lös 5 mmol/10ml Fertigspr
Market launch
15/12/2000
Narcotic (BTM)
No

Other packaging sizes

PROHANCE sol inj 8.5 mmol/17ml ser préremp
1 x 17 ML
View